Cited by 2,159Cannabis and Cannabinoid ResearchReceptor Mechanisms and SignalingNeuroscience and Neuropharmacology Research

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Open access

Herkenham, M, Lynn, AB, Johnson, MR, Melvin, LS, de Costa, BR, Rice, KC·1991·The Journal of Neuroscience

DOI 10.1523/jneurosci.11-02-00563.1991PMC PMC6575215

Open this paper in CoChat — free account Open PDF

Abstract

A potent, synthetic cannabinoid was radiolabeled and used to characterize and precisely localize cannabinoid receptors in slide-mounted sections of rat brain and pituitary. Assay conditions for 3H-CP55,940 binding in Tris-HCl buffer with 5% BSA were optimized, association and dissociation rate constants determined, and the equilibrium dissociation constant (Kd) calculated (21 nM by liquid scintillation counting, 5.2 nM by quantitative autoradiography). The results of competition studies, using several synthetic cannabinoids, add to prior data showing enantioselectivity of binding and correlation of in vitro potencies with potencies in biological assays of cannabinoid actions. Inhibition of binding by guanine nucleotides was selective and profound: Nonhydrolyzable analogs of GTP and GDP inhibited binding by greater than 90%, and GMP and the nonhydrolyzable ATP analog showed no inhibition. Autoradiography showed great heterogeneity of binding in patterns of labeling that closely conform to cytoarchitectural and functional domains. Very dense 3H-CP55,940 binding is localized to the basal ganglia (lateral caudate-putamen, globus pallidus, entopeduncular nucleus, substantia nigra pars reticulata), cerebellar molecular layer, innermost layers of the olfactory bulb, and portions of the hippocampal formation (CA3 and dentate gyrus molecular layer). Moderately dense binding is found throughout the remaining forebrain. Sparse binding characterizes the brain stem and spinal cord. Densitometry confirmed the quantitative heterogeneity of cannabinoid receptors (10 nM 3H-CP55,940 binding ranged in density from 6.3 pmol/mg protein in the substantia nigra pars reticulata to 0.15 pmol/mg protein in the anterior lobe of the pituitary). The results suggest that the presently characterized cannabinoid receptor mediates physiological and behavioral effects of natural and synthetic cannabinoids, because it is strongly coupled to guanine nucleotide regulatory proteins and is discretely localized to cortical, basal ganglia, and cerebellar structures involved with cognition and movement.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.11-02-00563.1991

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS
Gilman, A. G. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.003151 · Cited by 6,405
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Self-citation
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Self-citation
The organization of the projection from the cerebral cortex to the striatum in the rat
McGeorge, A. J., & Faull, R. L. M. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90128-0 · Cited by 1,360
Techniques of Autoradiography
Baserga, R. (1967) · JAMA · doi:10.1001/jama.1967.03130250093034 · Cited by 1,146
Hypoplasia of cerebellar vermal lobules VI and VII in autism
Courchesne, E., Yeung-Courchesne, R., Hesselink, J. R., & Jernigan, T. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182102 · Cited by 1,058
Techniques of autoradiography
Rogers, A. W. (1967) · Medical Entomology and Zoology · Cited by 1,026
The amygdalostriatal projection in the rat—an anatomical study by anterograde and retrograde tracing methods
Kelley, A. E., Domesick, V. B., & Nauta, W. J. H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90067-7 · Cited by 888

Show all 65 references

Research works printed but not linked: 3

Harris LS, Dewey WL, Razdan RK (1977) Cannabis. Its chemistry, pharmacology, and toxicology. In: Handbook of experimental phar- macology (Martin WR, ed), pp 37 l-%29. New York: Springer.
Margulies JE, Hammer RP (1991) THC alters cerebral metabolism in limbic and cortical regions in a biphasic, dose-dependent manner. Ale Drug Res, in press.
Pertwee RG (1985) Cannabis. In: Psychopharmacology 2, Pt 1: Pre- clinical psychopharmacology (Grahame-Smith DG, Cowan PJ, eds), pp 364-39 1. Amsterdam: Elsevier.

Sorted by citations

Items 201–300 of 1,009

Direct Actions of Cannabinoids on Synaptic Transmission in the Nucleus Accumbens: A Comparison With Opioids
Hoffman, A. F., & Lupica, C. R. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.1.72 · Cited by 194
Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure
Hoffman, A. F., Oz, M., Caulder, T., & Lupica, C. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04815.2003 · Cited by 193
Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?
Hill, M. N., & Gorzalka, B. B. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00006 · Cited by 196
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia
Mátyás, F., Yanovsky, Y., Mackie, K., Kelsch, W., Misgeld, U., & Freund, T. F. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.005 · Cited by 197
Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor
Hilairet, S., Bouaboula, M., Carrière, D., Fur, G. L., & Casellas, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212369200 · Cited by 191
Endocannabinoid system, stress and HPA axis
Micale, V., & Drago, F. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.039 · Cited by 189
Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia
Julian, M. D., Martin, A. B., Cuéllar, B., de Fonseca, F. R., Navarro, M. A., Moratalla, R., & García‐Segura, L. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00070-8 · Cited by 193
Cannabinoid Receptors and Their Role in Neuroprotection
van der Stelt, M., & Marzo, V. D. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:037 · Cited by 192
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area
Mátyás, F., Urbán, G. M., Watanabe, M., Mackie, K., Zimmer, A., Freund, T. F., & Katona, I. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.028 · Cited by 187
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Ortega-Álvaro, A., Aracil-Fernández, A., García‐Gutiérrez, M. S., Navarrete, F., & Manzanares, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.34 · Cited by 190
Increased ventral striatal BOLD activity during non-drug reward anticipation in cannabis users
Nestor, L., Hester, R., & Garavan, H. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.022 · Cited by 186
Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice
Shearman, L. P., Rosko, K., Fleischer, R., Wang, J., Xu, S., Tong, X., & Rocha, B. A. G. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200312000-00001 · Cited by 188
Endocannabinoids in the central nervous system-an overview
Fride, E. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0360 · Cited by 186
Cognitive Correlates of Long-term Cannabis Use in Costa Rican Men
Fletcher, J. M. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830110089011 · Cited by 187
Cannabis use for chronic non-cancer pain: results of a prospective survey
Ware, M. A., Doyle, C. R., Woods, R., Lynch, M. E., & Clark, A. J. (2003) · Pain · doi:10.1016/s0304-3959(02)00400-1 · Cited by 185
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors
den Boon, F. S., Chameau, P. J. P., Schaafsma-Zhao, Q., van Aken, W., Bari, M., Oddi, S., Kruse, C. G., Maccarrone, M., Wadman, W. J., & Werkman, T. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118167109 · Cited by 190
Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome
Jutras‐Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 188
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord
Hohmann, A. G., Briley, E. M., & Herkenham, M. A. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01321-3 · Cited by 183
Self-citation
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
Rice, A. S. C., Farquhar-Smith, W. P., & Nagy, I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0362 · Cited by 183
Functions of cannabinoid receptors in the hippocampus
Davies, S. N., Pertwee, R. G., & Riedel, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00060-6 · Cited by 184
Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia
Richardson, J. D., Aanonsen, L., & Hargreaves, K. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00451.1998 · Cited by 182
Cannabinoids and multiple sclerosis
Pertwee, R. G. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00255-3 · Cited by 181
Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas
Heng, L., Beverley, J. A., Steiner, H., & Tseng, K. Y. (2010) · Synapse · doi:10.1002/syn.20844 · Cited by 180
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
The Cannabinoid CB1 Receptor Mediates Retrograde Signals for Depolarization-Induced Suppression of Inhibition in Cerebellar Purkinje Cells
Yoshida, T., Hashimoto, K., Zimmer, A., Maejima, T., Araishi, K., & Kano, M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01690.2002 · Cited by 179
Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study
Oviedo, A., Glowa, J. R., & Herkenham, M. A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90220-h · Cited by 178
Self-citation
Endocannabinoids in the retina: From marijuana to neuroprotection
Yazulla, S. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.07.002 · Cited by 188
Cannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 177
The cannabinoid CB 1 receptor antagonist SR141716A attenuates the memory impairment produced by ? 9 -tetrahydrocannabinol or anandamide
Mallet, P. E., & Beninger, R. J. (1998) · Psychopharmacology · doi:10.1007/s002130050733 · Cited by 180
Distribution of the Endocannabinoid System in the Central Nervous System
Hu, S. S., & Mackie, K. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_3 · Cited by 187
Cannabinoid Receptor Modulation of Synapses Received by Cerebellar Purkinje Cells
Takahashi, K. A., & Linden, D. J. (2000) · Journal of Neurophysiology · doi:10.1152/jn.2000.83.3.1167 · Cited by 181
Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus
Richfield, E. K., & Herkenham, M. A. (1994) · Annals of Neurology · doi:10.1002/ana.410360406 · Cited by 177
Self-citation
Cannabinoid analgesia
Walker, J. M., & Huang, S. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00252-8 · Cited by 176
Function of Cannabinoid Receptors in the Neuroendocrine Regulation of Hormone Secretion
Murphy, L. L., Muñoz, R. M., Adrian, B., & Villanúa, M. Á. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0224 · Cited by 175
Stimulation of Cannabinoid Receptor CB1 Induces krox-24 Expression in Human Astrocytoma Cells
Bouaboula, M., Bourrié, B., Rinaldi, M. L., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13973 · Cited by 176
Downregulation of rat brain cannabinoid binding sites after chronic Δ9-tetrahydrocannabinol treatment
de Fonseca, F. R., Gorriti, M. Á., Fernández‐Ruíz, J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Two brain sites for cannabinoid reward
Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S. R., & Wise, R. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3554-05.2006 · Cited by 174
Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems
Solinas, M., & Goldberg, S. R. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300720 · Cited by 183
Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids
Campos, A. C., & Guimarães, F. S. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.08.017 · Cited by 172
Cannabinoids and prefrontal cortical function: Insights from preclinical studies
Egerton, A., Allison, C., Brett, R. R., & Pratt, J. A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.12.002 · Cited by 177
Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry
Bridges, D., Rice, A. S. C., Egertová, M., Elphick, M. R., Winter, J., & Michael, G. J. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00200-8 · Cited by 177
Physical withdrawal in rats tolerant to Δ9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
Tsou, K., Patrick, S. L., & Walker, J. M. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00360-w · Cited by 173
Mechanisms of Cannabinoid-Receptor–Mediated Inhibition of Synaptic Transmission in Cultured Hippocampal Pyramidal Neurons
Sullivan, J. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.3.1286 · Cited by 172
Cellular and Molecular Mechanisms Underlying Learning and Memory Impairments Produced by Cannabinoids: Figure 1.Preprint
Sullivan, J. (2000) · Learning & Memory · doi:10.1101/lm.7.3.132 · Cited by 175
The Therapeutic Potential of the Endocannabinoid System for the Development of a Novel Class of Antidepressants
Hill, M. N., Hillard, C. J., Bambico, F. R., Patel, S., Gorzalka, B. B., & Gobbi, G. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.006 · Cited by 175
The evolution and comparative neurobiology of endocannabinoid signalling
Elphick, M. R. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0394 · Cited by 180
Suppression of Noxious Stimulus-Evoked Activity in the Ventral Posterolateral Nucleus of the Thalamus by a Cannabinoid Agonist: Correlation between Electrophysiological and Antinociceptive Effects
Martin, W. J., Hohmann, A. G., & Walker, J. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06601.1996 · Cited by 172
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats
Lichtman, A. H. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00615-4 · Cited by 171
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma
Xu, X., Liu, Y., Huang, S., Liu, G., Xie, C., Zhou, J., Fan, W., Li, Q., Wang, Q., Zhong, D., et al. (2006) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2006.06.014 · Cited by 171
Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development
Berrendero, F., García-Gil, L., Hernández, M., Romero, J., Cebeira, M., de Miguel, R., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Development · doi:10.1242/dev.125.16.3179 · Cited by 174
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay
Kinsey, S. G., O'Neal, S. T., Long, J. Z., Cravatt, B. F., & Lichtman, A. H. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.002 · Cited by 170
Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis
Steiner, M. S., & Wotjak, C. T. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00433-0 · Cited by 174
Synergistic interactions of endogenous opioids and cannabinoid systems
Welch, S. P., & Eads, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01908-3 · Cited by 169
Δ9‐tetrahydrocannabinol‐induced MAPK/ERK and Elk‐1 activation in vivo depends on dopaminergic transmission
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R. J., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 179
Aversive effects of the synthetic cannabinoid CP 55,940 in rats
McGregor, I. S., Issakidis, C. N., & Prior, G. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02066-7 · Cited by 169
Molecular and cellular basis of cannabinoid and opioid interactions
Viganò, D., Rubino, T., & Parolaro, D. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.021 · Cited by 167
Role of the Endogenous Cannabinoid System in the Regulation of Motor Activity
de Fonseca, F. R., del Arco, I., Martín-Calderón, J. L., Gorriti, M. Á., & Navarro, M. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0217 · Cited by 167
Assessment of Anandamide Interaction with the Cannabinoid Brain Receptor: SR 141716A Antagonism Studies in Mice and Autoradiographic Analysis of Receptor Binding in Rat Brain
Adams, I. B., Compton, D. M., & Martin, B. R. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37342-2 · Cited by 165
Targeting Fatty Acid Amide Hydrolase (FAAH) to Treat Pain and Inflammation
Schlosburg, J. E., Kinsey, S. G., & Lichtman, A. H. (2009) · The AAPS Journal · doi:10.1208/s12248-008-9075-y · Cited by 169
An examination of the central sites of action of cannabinoid-induced antinociception in the rat
Martin, W. J., Patrick, S. L., Coffin, P. O., Tsou, K., & Walker, J. M. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00195-c · Cited by 168
Endocannabinoid signaling is critical for habit formation
Hilário, M. R. F. (2007) · Frontiers in Integrative Neuroscience · doi:10.3389/neuro.07.006.2007 · Cited by 164
“The expression of CB1 receptors in the brain displays an interesting gradient across the striatum, with a very high level of expression in the dorsolateral striatum (Gerdeman et al., 2003; Herkenham et al., 1991), at both excitatory and inhibitory terminals (Uchigashima et al., 2007).”
Influential
Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections
Martin, W. J., Coffin, P. O., Attias, E., Balinsky, M., Tsou, K., & Walker, J. M. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01368-7 · Cited by 164
Regional enhancement of cannabinoid CB1 receptor desensitization in female adolescent rats following repeated Δ9‐tetrahydrocannabinol exposure
Burston, J. J., Wiley, J. L., Craig, A. A., Selley, D. E., & Sim‐Selley, L. J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00870.x · Cited by 164
Increasing cannabinoid levels by pharmacological and genetic manipulation delays disease progression in SOD1 mice
Bilsland, L. G., Dick, J. R. T., Pryce, G., Petrosino, S., Marzo, V. D., Baker, D., & Greensmith, L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4743fje · Cited by 168
Stimulation of cannabinoid receptors reduces levodopa‐induced dyskinesia in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
Fox, S. H., Henry, B., Hill, M. P., Crossman, A. R., & Brotchie, J. M. (2002) · Movement Disorders · doi:10.1002/mds.10289 · Cited by 165
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Fernández‐Ruíz, J., Hernández, M., & Ramos, J. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00144.x · Cited by 163
Spinal cannabinoids are anti-allodynic in rats with persistent inflammation
Martin, W. J., Loo, C. M., & Basbaum, A. I. (1999) · Pain · doi:10.1016/s0304-3959(99)00045-7 · Cited by 166
A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
López-Sendón, J. L., Caldentey, J. G., Cubillo, P. T., Romero, C. R., Ribas, G. G., Arias, M. A. A. A., de Yébenes, M. J. G., Tolón, R. M., Galve‐Roperh, I., Sagredo, O., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8145-9 · Cited by 162
Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives
Hohmann, A. G. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00154-8 · Cited by 161
Despite substantial degradation, 2‐arachidonoylglycerol is a potent full efficacy agonist mediating CB 1 receptor‐dependent G‐protein activation in rat cerebellar membranes
Savinainen, J. R., Järvinen, T., Laine, K., & Laitinen, J. T. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704297 · Cited by 163
Δ9-Tetrahydrocannabinol Increases Prefrontal Cortical Catecholaminergic Utilization and Impairs Spatial Working Memory in the Rat: Blockade of Dopaminergic Effects with HA966
Jentsch, J. D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00018-3 · Cited by 159
Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea‐pig small intestine
Pertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R., & Corbett, A. D. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09088.x · Cited by 156
Are periaqueductal gray and dorsal raphe the foundation of appetitive and aversive control? A comprehensive review
Silva, C., & McNaughton, N. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.02.001 · Cited by 166
Reversal of Δ9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine
Williams, C. M., & Kirkham, T. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00694-3 · Cited by 157
Localization of the CB1 type cannabinoid receptor in the rat basolateral amygdala: high concentrations in a subpopulation of cholecystokinin-containing interneurons
McDonald, A. J., & Mascagni, F. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00380-3 · Cited by 157
Cannabis and endogenous cannabinoid systems
Childers, S. R., & Breivogel, C. S. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00075-1 · Cited by 157
Cannabinoid Receptors Can Activate and Inhibit G Protein-Coupled Inwardly Rectifying Potassium Channels in a Xenopus Oocyte Expression System
McAllister, S. D., Griffin, G., Satin, L. S., & Abood, M. E. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35147-x · Cited by 160
Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain
Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 159
The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats
Belue, R. C., Howlett, A. C., Westlake, T. M., & Hutchings, D. E. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)00053-g · Cited by 154
The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation
Watson, S., Chambers, D., Hobbs, C., Doherty, P., & Graham, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.02.001 · Cited by 154
Opioid and cannabinoid receptor-mediated regulation of the increase in adrenocorticotropin hormone and corticosterone plasma concentrations induced by central administration of Δ9-tetrahydrocannabinol in rats
Manzanares, J., Corchero, J., & Fuentes, J. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01756-4 · Cited by 152
Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice
García-Gutiérrez, M. S., & Manzanares, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110379507 · Cited by 153
Role of cannabis and endocannabinoids in the genesis of schizophrenia
Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 155
Adolescent exposure to cannabis as a risk factor for psychiatric disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405362 · Cited by 156
Trajectory of adolescent cannabis use on addiction vulnerability
Hurd, Y. L., Michaelides, M., Miller, M. L., & Jutras‐Aswad, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.028 · Cited by 160
n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice
Watanabe, S., Doshi, M., & Hamazaki, T. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(03)00056-5 · Cited by 168
Update on Treatment Guideline in Fibromyalgia Syndrome with Focus on Pharmacology
Kia, S., & Choy, E. (2017) · Biomedicines · doi:10.3390/biomedicines5020020 · Cited by 166
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
Wenzel, J. M., & Cheer, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.126 · Cited by 161
Cannabinoid-Induced Presynaptic Inhibition of Glutamatergic EPSCs in Substantia Gelatinosa Neurons of the Rat Spinal Cord
Morisset, V., & Urbán, L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.40 · Cited by 152
Increase in meso-prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids
Diana, M., Melis, M., & Gessa, G. L. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00292.x · Cited by 155
Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum
Sim, L. J., Selley, D. E., Xiao, R., & Childers, S. R. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00211-7 · Cited by 147
The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation
Bow, E. W., & Rimoldi, J. M. (2016) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s32171 · Cited by 153
Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system
Braida, D., Pozzi, M., Cavallini, R., & Sala, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00210-x · Cited by 152
Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray
Moreira, F. A., de Aguiar, D. C., & Guimarães, F. S. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.013 · Cited by 153
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
The CB1 Cannabinoid Receptor Can Sequester G-Proteins, Making Them Unavailable to Couple to Other Receptors
Vásquez, C., & Lewis, D. L. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09271.1999 · Cited by 150
Mitochondrial cAMP-PKA signaling: What do we really know?
Amer, Y. O., & Hébert-Chatelain, É. (2018) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2018.04.005 · Cited by 146
Endogenous cannabinoids as an aversive or counter-rewarding system in the rat.
Sañudo-Peña, M., Tsou, K., Delay, E., Hohman, A. G., Force, M., & Walker, J. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13424-3 · Cited by 156
Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions
Romero, J., García‐Palomero, E., Castro, J. G., García-Gil, L., Ramos, J. A., & Fernández‐Ruíz, J. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00277-x · Cited by 150
Survey of medicinal cannabis use among childbearing women: Patterns of its use in pregnancy and retroactive self-assessment of its efficacy against ‘morning sickness’
Westfall, R. E., Janssen, P. A., Lucas, P., & Capler, R. (2005) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2005.09.006 · Cited by 146

Authors: Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K.
Affiliations: National Institutes of Health (US)
ORCID: Herkenham, M
Venue: The Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 1991-02-01
Volume: 11
Issue: 2
Pages: 563-583
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.11-02-00563.1991
PMC: PMC6575215
OpenAlex: W1836729582
Cited by: 2,159
References: 65
Citations by year: 2026: 23 · 2025: 23 · 2024: 43 · 2023: 56 · 2022: 64 · 2021: 65 · 2020: 84 · 2019: 61 · 2018: 74 · 2017: 70 · 2016: 70 · 2015: 95 · 2014: 77 · 2013: 74 · 2012: 86
FWCI: 14.68
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-sa
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 181 d)
Locations: Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords: cannabinoid receptors, receptor localization, receptor density, G protein coupling, enantioselectivity, basal ganglia, cerebellar molecular layer, olfactory bulb, hippocampus, substantia nigra pars reticulata, pituitary gland, rat brain
MeSH terms: Animals, Autoradiography, Brain, Buffers, Cannabinoids, Cyclohexanols, Male, Rats, Inbred Strains, Receptors, Drug, Serum Albumin, Bovine, Temperature, Time Factors, Tissue Distribution, Receptors, Cannabinoid, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks